Søren Rytter1,2, Maiken Stilling3,4, Stig Munk3,5, Torben Bæk Hansen3,4,5. 1. Department of Orthopedics, University Clinic for Hand, Hip and Knee Surgery, Regional Hospital West Jutland, Lægårdvej 12, 7500, Holstebro, Denmark. soeren.rytter@vest.rm.dk. 2. Department of Clinical Medicine, University of Aarhus, Aarhus, Denmark. soeren.rytter@vest.rm.dk. 3. Department of Orthopedics, University Clinic for Hand, Hip and Knee Surgery, Regional Hospital West Jutland, Lægårdvej 12, 7500, Holstebro, Denmark. 4. Department of Clinical Medicine, University of Aarhus, Aarhus, Denmark. 5. The Lundbeck Center for Fast-Track Hip and Knee Arthroplasty, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Abstract
PURPOSE: Unicompartmental knee arthroplasty (UKA) results in less operative trauma and faster patient recovery than after a conventional total knee arthroplasty. Despite an increased focus on multimodal analgesic strategies, there is still a substantial level of patient-reported pain in the early postsurgical period after UKA. The purpose of the study was to evaluate the effect of a single preoperative dose of systemic methylprednisolone on postsurgical pain after fast-track UKA. METHODS: Seventy-two patients in two consecutive series undergoing unilateral UKA were included in a prospective cohort study. The patients (n = 35) in the treatment group received a single preoperative dose of systemic methylprednisolone 125 mg, whereas the control group (n = 37) did not. Outcome measures were postsurgical pain at rest and during walking, consumption of opioids for pain rescue, knee swelling and knee range of motion, and complications. RESULTS: In the first 24 h after surgery, the treatment group had less pain at rest (p < 0.001) and during walking (p < 0.001) and less consumption of opioids (p = 0.01) in comparison with the control group. Furthermore, the treatment group had 2.2 cm less knee swelling (p = 0.02) in the first post-operative day, and better knee extension (p = 0.004), whereas knee flexion was similar (n.s.) between groups. No serious complications were associated with the treatment. CONCLUSION: Addition of a single preoperative dose of 125 mg systemic methylprednisolone to a multimodal analgesic regime significantly reduced postsurgical pain and opioid consumption and decreased knee swelling in the first 24 h after fast-track UKA. LEVEL OF EVIDENCE: Therapeutic study, Level II.
PURPOSE: Unicompartmental knee arthroplasty (UKA) results in less operative trauma and faster patient recovery than after a conventional total knee arthroplasty. Despite an increased focus on multimodal analgesic strategies, there is still a substantial level of patient-reported pain in the early postsurgical period after UKA. The purpose of the study was to evaluate the effect of a single preoperative dose of systemic methylprednisolone on postsurgical pain after fast-track UKA. METHODS: Seventy-two patients in two consecutive series undergoing unilateral UKA were included in a prospective cohort study. The patients (n = 35) in the treatment group received a single preoperative dose of systemic methylprednisolone 125 mg, whereas the control group (n = 37) did not. Outcome measures were postsurgical pain at rest and during walking, consumption of opioids for pain rescue, knee swelling and knee range of motion, and complications. RESULTS: In the first 24 h after surgery, the treatment group had less pain at rest (p < 0.001) and during walking (p < 0.001) and less consumption of opioids (p = 0.01) in comparison with the control group. Furthermore, the treatment group had 2.2 cm less knee swelling (p = 0.02) in the first post-operative day, and better knee extension (p = 0.004), whereas knee flexion was similar (n.s.) between groups. No serious complications were associated with the treatment. CONCLUSION: Addition of a single preoperative dose of 125 mg systemic methylprednisolone to a multimodal analgesic regime significantly reduced postsurgical pain and opioid consumption and decreased knee swelling in the first 24 h after fast-track UKA. LEVEL OF EVIDENCE: Therapeutic study, Level II.
Authors: Nicholas M Brown; Neil P Sheth; Kenneth Davis; Mike E Berend; Adolph V Lombardi; Keith R Berend; Craig J Della Valle Journal: J Arthroplasty Date: 2012-05-04 Impact factor: 4.757
Authors: Joseph S Gondusky; Leera Choi; Naila Khalaf; Jay Patel; Steven Barnett; Robert Gorab Journal: J Arthroplasty Date: 2013-10-31 Impact factor: 4.757
Authors: Christian Bredgaard Jensen; Anders Troelsen; Christian Skovgaard Nielsen; Niels Kristian Stahl Otte; Henrik Husted; Kirill Gromov Journal: Acta Orthop Date: 2020-04-14 Impact factor: 3.717